Argentina Medical Device Registration: Core Dossier Documents under GMC 25/21

1. Key takeaways

Part III, Article 6 of GMC 25/21 enumerates the five categories of basic submission documents that every medical device registration dossier in Argentina must contain:

1. Proof of payment of the applicable fees, retained together with the corresponding receipt;
2. Identification information for the manufacturer, the importer and the product, prepared in the formats of Annexes III/IV/V and signed by both the legal representative and the technical director;
3. The manufacturer’s authorization statement, valid for 2 years from the date of issue, expressly authorizing that Argentine importer to represent the manufacturer and market its products in Argentina, stating the full legal names and complete addresses of both parties, and legalized or apostilled with a certified translation attached;
4. The registration certificate of the country of origin and/or country of sale, or a Certificate of Free Sale, valid for 2 years from the date of issue where no validity period is stated, and likewise legalized or apostilled with a certified translation attached;
5. Proof of conformity with the product-specific technical regulation applicable to the device.

Beyond these five statutory categories, a complete dossier in practice must also include: a current ISO 13485 certificate, Spanish-language labels and instructions for use (IFU), the technical report, the risk management report and test reports. Class III/IV submissions usually also require clinical evaluation documentation. Treating the Article 6 list as the whole story is the most common planning error: the five basic documents get a file through administrative screening, while the technical documents determine how deeply the file is reviewed.

A practical reading of Article 6 is that it defines the floor, not the ceiling, of a dossier. ANMAT examiners use the five basic categories to confirm that the applicant, the product and the legal chain behind the submission are properly established, and they use the technical package to judge the device itself. Planning the two tracks separately, with different owners and different timelines inside the project, is the most reliable way to keep a submission moving without rework.

2. Legal basis

These instruments operate in layers. GMC 25/21 sets the MERCOSUR-level registration architecture and its annexes fix the document formats, while Disposición ANMAT 64/2025 transposes that architecture into Argentine domestic law and confirms the document list that ANMAT examiners actually apply. Disposición ANMAT 3266/2013 governs the GMP evidence expected from manufacturers, and GMC/RES 72/98 supplies the essential requirements on safety and effectiveness against which the technical documentation is drafted.

3. Expert insights

Insight 1: three of the five basic documents involve a legalization chain. The manufacturer’s authorization statement and the Certificate of Free Sale must be legalized or apostilled and accompanied by a certified Spanish translation, and the identification information must be signed jointly by the legal representative and the technical director. These three items are the highest-frequency grounds for rejection at the formal screening stage, and they are all formal defects that can be eliminated entirely before submission. None of them requires technical judgment; they require only sequencing and discipline in preparing the paperwork.

Insight 2: the 2-year validity is a default rule, not a hard deadline. The text reads that where no validity period is stated, a document is valid for 2 years from the date of issue. If the document itself states a shorter validity period, the stated period prevails; if it states a longer one, prudent practice is still to refresh the document on a rolling basis within the 2-year window, so that the review period does not straddle an expiry date. A certificate that lapses mid-review can undo months of waiting.

Insight 3: the technical documents outside the five basic categories are the real substance of the review. The technical report, the risk management report, the test reports and the clinical evaluation documentation do not appear in the Article 6 list, but they form the body of the technical assessment. Simplified pathways, such as the affidavit and declaration-of-conformity routes, do not waive the obligation to prepare these documents; they only spare the file a full review. Preparing them carelessly on the assumption that a simplified pathway makes them irrelevant is a costly misconception.

4. Practical recommendations

1. Manage the dossier with two parallel checklists: the five basic documents plus the technical documents. Verify the basic five item by item against the legalization and signature requirements, and draft the technical documents against the requirements of technical sufficiency. Tick the two lists separately so that formal completeness and technical completeness are tracked independently.
2. Start the legalization chain first. Issuance, apostille or consular legalization, and certified translation of the CFS and the authorization statement are the three slowest steps, and they should be initiated before the technical writing begins, because their lead times cannot be compressed at the end of a project.
3. Complete the identification information strictly in the annex formats. Annexes III/IV/V are fixed formats and must not be simplified unilaterally; signatures must be provided by both the legal representative and the technical director.
4. Run a validity dashboard for expiring documents. Consolidate the expiry dates of the authorization statement, the CFS and the ISO 13485 certificate in one place, and trigger renewal three months before each expiry so that no document lapses inside a review window.

5. Verification checklist

• □ Proof of payment made under the current fee schedule and the receipt retained
• □ Identification information completed in the Annex III/IV/V formats and signed by both signatories
• □ Manufacturer’s authorization statement issued less than 2 years ago, with legalization and translation in place
• □ Certificate of Free Sale within the applicable validity rule (no more than 2 years where none is stated)
• □ Proof of conformity with the product-specific technical regulation issued for the device class
• □ ISO 13485 certificate, Spanish labels and IFU, technical report and risk management report all in place

Regulatory information verified as of October 29, 2026.

In Argentina, GRZAN operates a wholly owned subsidiary that can serve as the registration holder and importer of record for foreign manufacturers, directly handling classification assessment, pathway selection, building the GMP and CFS documentation chain, Spanish-language localization of technical documentation and labeling, HELENA submissions and responses to deficiency letters, as well as BONITA import notifications, operation of the ARGOS vigilance system, change maintenance and planning for the 5-year renewal. For support with registration dossiers and conformity documentation for the Argentine market, contact the GRZAN regulatory team at info@grzanglobal.com.

The GRZAN regulatory team consists of professionals with many years of hands-on experience in international registrations, tracks the activity of regulatory authorities across markets on an ongoing basis, and applies a writing standard of conclusions first, traceable sources and verifiable figures to everything it publishes. For a market access plan tailored to a specific product in Argentina or the wider MERCOSUR region, the GRZAN regulatory team welcomes your enquiry at info@grzanglobal.com.